AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17040558 — intervention group
Group type: COMPARATOR
Intervention: Consultation with an orthopaedic specialist
Number of subjects: 0
Study 12648114 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation using boluses of propofol
Number of subjects: 23
Study 12648114 — intervention group
Group type: COMPARATOR
Intervention: Patient-maintained sedation using a target-controlled infusion of propofol
Number of subjects: 23
Study 12648114 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled sedation
Number of subjects: 23
Study 10738427 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic compression devices (pulsatile calf and foot and calf pneumatic compression with rapid inflation time)
Number of subjects: 10
Study 10738427 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic compression devices (compression of the calf and thigh)
Number of subjects: 10
Study 10738427 — intervention group
Group type: EXPERIMENTAL
Intervention: Active dorsoplantar flexion
Number of subjects: 10
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic gastritis in intestinal cancer (distal location)
Number of subjects: 3435
Study 8927748 — intervention group
Group type: COMPARATOR
Intervention: Atrophic gastritis in diffuse cancer (tumour-free area)
Number of subjects: 3435
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic pangastritis in intestinal distal cancer
Number of subjects: 3435
Study 8927748 — intervention group
Group type: COMPARATOR
Intervention: Atrophic pangastritis in diffuse proximal cancer
Number of subjects: 3435
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic pangastritis in intestinal proximal cancer
Number of subjects: 3435
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic pangastritis in diffuse distal carcinoma
Number of subjects: 3435
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic pangastritis association with gastric cancer
Number of subjects: 3435
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic pangastritis association with intestinal gastric cancer
Number of subjects: 3435
Study 8927748 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrophic pangastritis association with diffuse carcinoma
Number of subjects: 3435
Study 1425899 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 15 micrograms.kg‐1, vecuronium 0.01 mg.kg‐1, thiopentone 3‐4 mg.kg‐1, suxamethonium 1 mg.kg‐1
Number of subjects: 40
Study 1425899 — intervention group
Group type: COMPARATOR
Intervention: vecuronium 0.01 mg.kg‐1, thiopentone 3‐4 mg.kg‐1, suxamethonium 1 mg.kg‐1
Number of subjects: 40
Study 4064558 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (intravenous administration)
Number of subjects: 23
Study 31167901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings (four versions)
Number of subjects: 876
Study 31167901 — intervention group
Group type: COMPARATOR
Intervention: Text-only warning
Number of subjects: 876
Study 29579308 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole plus prednisone
Number of subjects: 173
Study 29579308 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 173
Study 27302646 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 206
Study 27302646 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 206
Study 24558098 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths‐Based/Professional Only (PO)
Number of subjects: 0
Study 24558098 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths‐Based/Professional‐Peer (PP)
Number of subjects: 0
Study 23069487 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene intervention (alcohol-based hand sanitizer, hand soap, and hand hygiene education)
Number of subjects: 527
Study 23069487 — intervention group
Group type: COMPARATOR
Intervention: Usual hand hygiene practices
Number of subjects: 527
Study 20711087 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive removal of silicone oil with 23-G transconjunctival sutureless system
Number of subjects: 40
Study 20711087 — intervention group
Group type: COMPARATOR
Intervention: 20-G active silicone oil removal using all three 20-G ports
Number of subjects: 40
Study 18652603 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab therapy (160 mg loading dose at week 0, 80 mg at week 2, 40 mg every other week starting at week 4)
Number of subjects: 13
Study 18652603 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab therapy
Number of subjects: 13
Study 15740542 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (250 mg, orally, twice daily during antibiotic treatment)
Number of subjects: 269
Study 15740542 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 269
Study 12093442 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-induced-viscosity (I-V) complex in glucose beverage
Number of subjects: 30
Study 12093442 — intervention group
Group type: COMPARATOR
Intervention: Control (glucose-based beverage with similar total dietary fiber level and initial viscosity)
Number of subjects: 30
Study 10657576 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 56
Study 8777661 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial sweet-tasting solution
Number of subjects: 60
Study 8777661 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% sucrose solution
Number of subjects: 60
Study 8777661 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% sucrose solution
Number of subjects: 60
Study 8777661 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 60
Study 1610998 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's (LR) solution (group I)
Number of subjects: 36
Study 1610998 — intervention group
Group type: EXPERIMENTAL
Intervention: LR with 5% dextrose solution (group II)
Number of subjects: 36
Study 6706438 — intervention group
Group type: EXPERIMENTAL
Intervention: pirbuterol 20 mg
Number of subjects: 16
Study 30782894 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Pelvic Floor Muscle Training (PFMT)
Number of subjects: 40
Study 30782894 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback-mediated Pelvic Floor Muscle Training (PFMT)
Number of subjects: 40
Study 29641819 — intervention group
Group type: EXPERIMENTAL
Intervention: Social worker-led palliative care intervention
Number of subjects: 50
Study 29641819 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 50
Study 26197031 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg · d(‐1) for 6 months
Number of subjects: 418
Study 26197031 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 418
Study 24512477 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program
Number of subjects: 18
Study 22446975 — intervention group
Group type: EXPERIMENTAL
Intervention: Assets‐Getting To Outcomes (AGTO) intervention
Number of subjects: 12
Study 22446975 — intervention group
Group type: COMPARATOR
Intervention: Control group (not using AGTO)
Number of subjects: 12
Study 20233153 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight maintenance interventions following family-based behavioral weight loss treatment for HIGH children (n = 71)
Number of subjects: 201
Study 20233153 — intervention group
Group type: COMPARATOR
Intervention: Weight maintenance interventions following family-based behavioral weight loss treatment for LOW children (n = 130)
Number of subjects: 201
Study 20233153 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent psychopathology
Number of subjects: 201
Study 17376109 — intervention group
Group type: EXPERIMENTAL
Intervention: Noonan syndrome group (NS)
Number of subjects: 22
Study 17376109 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 15705119 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity acenocoumarol (target INR 1.5 to 2.0)
Number of subjects: 19
Study 15705119 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 19
Study 11680026 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based participatory research (CBPR) partnership involving community-based organizations, a local health department, academia, and an integrated health care system.
Number of subjects: 0
Study 9258760 — intervention group
Group type: EXPERIMENTAL
Intervention: OsteoDyne's Hip Positioner System (HPS)
Number of subjects: 70
Study 9258760 — intervention group
Group type: COMPARATOR
Intervention: Standard hip positioner (Hologic)
Number of subjects: 70
Study 9258760 — intervention group
Group type: COMPARATOR
Intervention: Standard hip positioner (Lunar)
Number of subjects: 70
Study 8502770 — intervention group
Group type: EXPERIMENTAL
Intervention: Convoluted foam overlay
Number of subjects: 84
Study 8502770 — intervention group
Group type: COMPARATOR
Intervention: Solid foam overlay
Number of subjects: 84
Study 3319817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg sublingually
Number of subjects: 30
Study 3319817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2806274 — intervention group
Group type: EXPERIMENTAL
Intervention: Telebrix Gastro (ioxithalamate)
Number of subjects: 100
Study 2806274 — intervention group
Group type: COMPARATOR
Intervention: Gastrografin (amidotrizoate)
Number of subjects: 100
Study 5683581 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron plus 330 mug. of folic acid a day
Number of subjects: 0
Study 5683581 — intervention group
Group type: COMPARATOR
Intervention: Iron alone
Number of subjects: 0
Study 31280074 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient energy management education (IEME)
Number of subjects: 47
Study 31280074 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 47
Study 29206136 — intervention group
Group type: EXPERIMENTAL
Intervention: Diascorea extracts (12 mg/dose, 2 sachets daily)
Number of subjects: 50
Study 29206136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 25710190 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Bull (9.4 mL/kg body mass containing 3 mg/kg body mass caffeine)
Number of subjects: 11
Study 25710190 — intervention group
Group type: EXPERIMENTAL
Intervention: Anhydrous caffeine (3 mg/kg body mass in capsule form)
Number of subjects: 11
Study 25710190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 23105124 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered bone marrow biopsy device (OnControl())
Number of subjects: 50
Study 23105124 — intervention group
Group type: COMPARATOR
Intervention: Standard manual device (TRAP Hospital System)
Number of subjects: 50
Study 23105124 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices (with sedation)
Number of subjects: 50
Study 23105124 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices (no sedation)
Number of subjects: 50
Study 22137516 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS‐guided target‐controlled infusion of propofol
Number of subjects: 40
Study 22137516 — intervention group
Group type: COMPARATOR
Intervention: Manual control of propofol
Number of subjects: 40
Study 19384758 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute anterior uveitis (AAU) eyes
Number of subjects: 20
Study 19384758 — intervention group
Group type: COMPARATOR
Intervention: Healthy eyes (control)
Number of subjects: 20
Study 17059650 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine continence programme (TCP)
Number of subjects: 58
Study 17059650 — intervention group
Group type: COMPARATOR
Intervention: Conventional outpatient continence service (CS)
Number of subjects: 58
Study 14759561 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol kg(‐1) min(‐1))
Number of subjects: 17
Study 14759561 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 17
Study 11549203 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 alone
Number of subjects: 0
Study 11549203 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 plus lymphokine-activated killer cells
Number of subjects: 0
Study 11549203 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 plus IFN alpha
Number of subjects: 0
Study 11549203 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumour-infiltrating lymphocytes, IL-2 and IFN alpha
Number of subjects: 0
Study 11549203 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 0
Study 9294097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpregnant fertile women (group 1)
Number of subjects: 78
Study 9294097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpregnant women with RSA (group 2)
Number of subjects: 78
Study 9294097 — intervention group
Group type: COMPARATOR
Intervention: Healthy pregnant women (group 3)
Number of subjects: 78
Study 9294097 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women with RSA (group 4)
Number of subjects: 78
Study 8336878 — intervention group
Group type: EXPERIMENTAL
Intervention: Pliable Silastic cup
Number of subjects: 100
Study 8336878 — intervention group
Group type: COMPARATOR
Intervention: Rigid Malmström cup
Number of subjects: 100
Study 8336878 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cups
Number of subjects: 100
Study 3534261 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 34
Study 3534261 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 34
Study 28801001 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based palliative heart failure (HPHF) program
Number of subjects: 84
Study 28801001 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 27441869 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored website
Number of subjects: 1065
Study 27441869 — intervention group
Group type: COMPARATOR
Intervention: Nontailored website
Number of subjects: 1065
Study 24817819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% plus perineural dexamethasone 4 mg (group Dperi)
Number of subjects: 39
Study 24817819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% plus intravenous dexamethasone 4 mg (group Div)
Number of subjects: 39
Study 24817819 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.75% (group C)
Number of subjects: 39
Study 21967191 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (5 Hz)
Number of subjects: 20
Study 21967191 — intervention group
Group type: COMPARATOR
Intervention: Sham placebo
Number of subjects: 20
Study 20205574 — intervention group
Group type: EXPERIMENTAL
Intervention: Central PA mobilization
Number of subjects: 60
Study 20205574 — intervention group
Group type: COMPARATOR
Intervention: Random mobilization
Number of subjects: 60
Study 20205574 — intervention group
Group type: EXPERIMENTAL
Intervention: Both mobilization techniques
Number of subjects: 60
Study 18258393 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulgels containing flurbiprofen
Number of subjects: 0
Study 16787138 — intervention group
Group type: EXPERIMENTAL
Intervention: PDE3 inhibitors
Number of subjects: 0
Study 16787138 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with beta-adrenergic receptor antagonists
Number of subjects: 0
Study 16787138 — intervention group
Group type: EXPERIMENTAL
Intervention: PDE5 inhibitors
Number of subjects: 0
Study 16787138 — intervention group
Group type: COMPARATOR
Intervention: Other vasodilators
Number of subjects: 0
Study 12841882 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring releasing estradiol acetate (50 microg/day) plus placebo tablets
Number of subjects: 159
Study 12841882 — intervention group
Group type: COMPARATOR
Intervention: Oral estradiol (1 mg/day) plus placebo vaginal ring
Number of subjects: 159
Study 12841882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 159
Study 12841882 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring
Number of subjects: 159
Study 10648342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.15 mg
Number of subjects: 120
Study 10648342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg
Number of subjects: 120
Study 10648342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramosetron 0.6 mg
Number of subjects: 120
Study 10648342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 9709353 — intervention group
Group type: COMPARATOR
Intervention: Closed chest compressions on the ground
Number of subjects: 10
Study 9709353 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed chest compressions in the MB 510 ambulance
Number of subjects: 10
Study 9709353 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed chest compressions in the MB 310 ambulance
Number of subjects: 10
Study 9709353 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed chest compressions in the VW T4 ambulance
Number of subjects: 10
Study 8325043 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate via 'Autohaler' inhalation device
Number of subjects: 36
Study 8325043 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate via conventional metered dose inhaler
Number of subjects: 36
Study 3822496 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (5 mg/kg body weight)
Number of subjects: 0
Study 3822496 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 0
Study 31600349 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin
Number of subjects: 0
Study 31600349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28611089 — intervention group
Group type: EXPERIMENTAL
Intervention: Free and convenient access to a carefully selected list of 125 essential medicines (based on the WHO's Model List of Essential Medicines)
Number of subjects: 0
Study 28611089 — intervention group
Group type: COMPARATOR
Intervention: Usual means of medicine access
Number of subjects: 0
Study 26132939 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 3731
Study 26132939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3731
Study 23244366 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 67
Study 23244366 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy (IPT)
Number of subjects: 67
Study 23244366 — intervention group
Group type: COMPARATOR
Intervention: Control (No sudden gains)
Number of subjects: 67
Study 22080025 — intervention group
Group type: EXPERIMENTAL
Intervention: Red light (R)
Number of subjects: 120
Study 22080025 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescent light (DR)
Number of subjects: 120
Study 22080025 — intervention group
Group type: COMPARATOR
Intervention: Natural daylight (DF)
Number of subjects: 120
Study 18573394 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery
Number of subjects: 164
Study 18573394 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 164
Study 16543745 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance misuse with psychiatric concurrent disorders
Number of subjects: 0
Study 16543745 — intervention group
Group type: COMPARATOR
Intervention: Substance misuse only
Number of subjects: 0
Study 14507560 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 90
Study 14507560 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 90
Study 14507560 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg of 0.5% hyperbaric bupivacaine
Number of subjects: 90
Study 10713626 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral Blood Stem Cell (PBSC) collection
Number of subjects: 40
Study 10713626 — intervention group
Group type: COMPARATOR
Intervention: Bone Marrow (BM) collection
Number of subjects: 40
Study 8680049 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0
Study 1642526 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine-lying back extension (SBE) exercise
Number of subjects: 34
Study 1642526 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone-lying back extension (PBE) exercise
Number of subjects: 34
Study 1642526 — intervention group
Group type: COMPARATOR
Intervention: No exercise training (Control)
Number of subjects: 34
Study 6844470 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 48
Study 6844470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 6844470 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly sessions with one therapist
Number of subjects: 48
Study 6844470 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly sessions with one therapist
Number of subjects: 48
Study 6844470 — intervention group
Group type: EXPERIMENTAL
Intervention: Two therapists (male/female pair)
Number of subjects: 48
Study 6844470 — intervention group
Group type: EXPERIMENTAL
Intervention: One therapist (female)
Number of subjects: 48
Study 30221566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRG-loaded NVTEs vaginal gel
Number of subjects: 0
Study 30286920 — intervention group
Group type: COMPARATOR
Intervention: None hypoglycemia
Number of subjects: 1984
Study 30286920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypoglycemia
Number of subjects: 1984
Study 30286920 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypoglycemia
Number of subjects: 1984
Study 30286920 — intervention group
Group type: EXPERIMENTAL
Intervention: Less than weekly hypoglycemia
Number of subjects: 1984
Study 30286920 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater than or equal to weekly hypoglycemia
Number of subjects: 1984
Study 27022635 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.0 mm-long implants
Number of subjects: 150
Study 27022635 — intervention group
Group type: COMPARATOR
Intervention: 8.5 mm-long implants
Number of subjects: 150
Study 25124505 — intervention group
Group type: EXPERIMENTAL
Intervention: Group anger management treatment (AMT)
Number of subjects: 109
Study 22011557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine 15 mg
Number of subjects: 120
Study 22011557 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 50 mg
Number of subjects: 120